285 related articles for article (PubMed ID: 24519437)
21. Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism.
Friedman K; Somervell H; Patel P; Melton GB; Garrett-Mayer E; Dackiw AP; Civelek AC; Zeiger MA
Surgery; 2004 Dec; 136(6):1199-204. PubMed ID: 15657576
[TBL] [Abstract][Full Text] [Related]
22. The relationship between technetium-99m-methoxyisobutyl isonitrile parathyroid scintigraphy and hormonal and biochemical markers in suspicion of primary hyperparathyroidism.
Silov G; Ozdal A; Erdoğan Z; Turhal O; Karaman H
Mol Imaging Radionucl Ther; 2013 Apr; 22(1):8-13. PubMed ID: 23610725
[TBL] [Abstract][Full Text] [Related]
23. Sestamibi parathyroid scintigraphy in multigland disease.
Nichols KJ; Tomas MB; Tronco GG; Palestro CJ
Nucl Med Commun; 2012 Jan; 33(1):43-50. PubMed ID: 22001718
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of conventional imaging techniques on preoperative localization in primary hyperparathyroidism.
Ozkaya M; Elboga U; Sahin E; Kalender E; Korkmaz H; Demir HD; Celen YZ; Erkılıç S; Gökalp A; Maralcan G
Bosn J Basic Med Sci; 2015 Feb; 15(1):61-6. PubMed ID: 25725146
[TBL] [Abstract][Full Text] [Related]
25. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism.
Parikshak M; Castillo ED; Conrad MF; Talpos GB
Am Surg; 2003 May; 69(5):393-8; discussion 399. PubMed ID: 12769210
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism.
Martínez-Rodríguez I; Martínez-Amador N; de Arcocha-Torres M; Quirce R; Ortega-Nava F; Ibáñez-Bravo S; Lavado-Pérez C; Bravo-Ferrer Z; Carril JM
Rev Esp Med Nucl Imagen Mol; 2014; 33(2):93-8. PubMed ID: 24125595
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic and radiopharmacokinetic factors affecting gamma probe-guided parathyroidectomy.
Ugur O; Bozkurt MF; Hamaloglu E; Sokmensuer C; Etikan I; Ugur Y; Sayek I; Gulec SA
Arch Surg; 2004 Nov; 139(11):1175-9. PubMed ID: 15545562
[TBL] [Abstract][Full Text] [Related]
28. The usefulness of preoperative dual-phase 99mTc MIBI-scintigraphy and IO-PTH assay in the treatment of secondary and tertiary hyperparathyroidism.
Gasparri G; Camandona M; Bertoldo U; Sargiotto A; Papotti M; Raggio E; Nati L; Martino P; Felletti G; Mengozzi G
Ann Surg; 2009 Dec; 250(6):868-71. PubMed ID: 19855263
[TBL] [Abstract][Full Text] [Related]
29. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience.
Ciappuccini R; Morera J; Pascal P; Rame JP; Heutte N; Aide N; Babin E; Reznik Y; Bardet S
Clin Nucl Med; 2012 Mar; 37(3):223-8. PubMed ID: 22310246
[TBL] [Abstract][Full Text] [Related]
30. Preoperative localization of parathyroid adenomas with technetium-99m methoxyisobutylisonitrile imaging: relationship with P-glycoprotein expression, oxyphilic cell content, and tumoral tissue volume.
Turgut B; Elagoz S; Erselcan T; Koyuncu A; Dokmetas HS; Hasbek Z; Ozdemir S; Aydin C
Cancer Biother Radiopharm; 2006 Dec; 21(6):579-90. PubMed ID: 17257073
[TBL] [Abstract][Full Text] [Related]
31. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy.
Thomas DL; Bartel T; Menda Y; Howe J; Graham MM; Juweid ME
Clin Nucl Med; 2009 Oct; 34(10):651-5. PubMed ID: 19893394
[TBL] [Abstract][Full Text] [Related]
32. Multiple myeloma: predictive value of Tc-99m MIBI scintigraphy and MRI in its diagnosis and therapy.
Myslivecek M; Nekula J; Bacovsky J; Scudla V; Koranda P; Kaminek M
Nucl Med Rev Cent East Eur; 2008; 11(1):12-6. PubMed ID: 19173182
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging (MRI) and technetium-99m-methoxyisonitrile (MIBI) scintigraphy to evaluate the abnormal parathyroid gland and PEIT efficacy for secondary hyperparathyroidism.
Wada A; Sugihara M; Sugimura K; Kuroda H
Radiat Med; 1999; 17(4):275-82. PubMed ID: 10510900
[TBL] [Abstract][Full Text] [Related]
34. Can the use of intraoperative intact parathyroid hormone monitoring be abandoned in patients with hyperparathyroidism?
Sakimura C; Minami S; Hayashida N; Uga T; Inokuchi N; Eguchi S
Am J Surg; 2013 Oct; 206(4):574-7. PubMed ID: 23827512
[TBL] [Abstract][Full Text] [Related]
35. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
36. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
Rubello D; Saladini G; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
[TBL] [Abstract][Full Text] [Related]
38. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
Casara D; Rubello D; Pelizzo MR; Shapiro B
Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
[TBL] [Abstract][Full Text] [Related]
39. Factors affecting the sensitivity of Tc-99m methoxyisobutylisonitrile dual-phase parathyroid single photon emission computed tomography in primary hyperparathyroidism.
Araz M; Çayir D; Erdoğan M; Uçan B; Çakal E
Nucl Med Commun; 2017 Feb; 38(2):117-123. PubMed ID: 27846041
[TBL] [Abstract][Full Text] [Related]
40. Technetium-99m 2-methoxy-isobutyl-isonitrile uptake scintigraphy in detection of the bone marrow infiltration in multiple myeloma: correlation with MRI and other prognostic factors.
Erten N; Saka B; Berberoglu K; Turkmen C; Unal S; Bakir B; Yekeler E; Besisik SK
Ann Hematol; 2007 Nov; 86(11):805-13. PubMed ID: 17684742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
